Clinical Trials Browser

Phase 3 × Esophageal Neoplasms × Tegafur × Clear all

NCT04415853 2025-05-18

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms